The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.

ASH 2025 highlighted innovative cancer treatments, including in vivo CAR T therapy and options that enhance quality of life ...

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Here are the top 5 most-read CRC articles in 2025. From cutting-edge AI detection tools to rising incidence in younger adults ...

The top read ophthalmology articles of 2025 focused on a variety of topics within the field, including links between ...

In the EPCORE DLBCL-3 study, fixed-duration epcoritamab monotherapy delivered deep, durable responses with manageable ...

A reimbursable, team-based remote blood pressure monitoring program significantly improved hypertension control in patients ...

Expanding service lines in community oncology practices enhances patient experience and strengthens community ties, offering ...

Here are the most-read “5 things” articles from 2025.

High risk of obstructive sleep apnea (OSA) is linked to a 40% increase in poor mental health outcomes, including depression ...

As therapy for chronic lymphocytic leukemia (CLL) continues to evolve, 2025 brought research, regulatory news, and expert ...